Draft UK POPs Regulations 2026: The Biggest Item on the Horizon for Defence Clients

Of everything currently moving through the UK and EU regulatory pipeline, the draft UK POPs (Amendment) Regulations 2026 is the single biggest item on the horizon for defence supply chains right now, ahead of any individual SVHC listing or CLP change we’ve flagged recently. It’s still a draft, but it’s a draft worth planning around today, not once it’s finalised.

What the draft actually covers

DEFRA ran a consultation on the amendment from 18 March to 13 May 2026, and the government response hasn’t been published yet. The draft covers Medium-Chain Chlorinated Paraffins (MCCPs), long-chain PFCAs, UV-328, Dechlorane Plus and chlorpyrifos, alongside a revision of the unintentional trace contaminant limits for PFOS. Per the WTO notification, proposed adoption is 14 October 2026, with entry into force proposed for 16 December 2026. Those are proposed dates from the notification, not confirmed law, and worth verifying against the instrument itself before relying on them for client advice.

Why a POPs listing is a different order of problem to an SVHC listing

An SVHC listing on the Candidate List brings communication duties: you tell people a substance is present above a threshold. A POPs listing is a different mechanism entirely, and it typically means restriction on manufacture, use and placing on the market, with only narrow, defined exemptions. If any of these five substance groups are confirmed in your supply chain, this isn’t a “update the SDS” problem, it’s a “can we still use this at all” problem.

The defence and aerospace exemption question

The draft flags time-limited exemptions for aerospace, defence and medical devices. That’s a meaningful signal that the drafters know these sectors have genuine, hard-to-substitute uses. But time-limited means exactly that: an exemption with a clock attached, not a permanent carve-out, and it’s still sitting inside a draft that hasn’t been adopted. Don’t assume any specific component or application is automatically covered without checking the exemption’s actual scope once it’s confirmed.

Why MCCPs deserve particular attention

MCCPs are worth watching closely because they’re moving on two separate regulatory tracks at once: this POPs restriction process, and the UK Candidate List consultation we covered a few weeks ago. Two different regulatory routes converging on the same substance in the same year is a strong signal that MCCPs are heading for real restriction, not just heightened scrutiny, regardless of which mechanism gets there first.

What to do now

• Identify where MCCPs, long-chain PFCAs, UV-328, Dechlorane Plus and chlorpyrifos appear across your defence and aerospace supply chains, including in components sourced through multiple tiers.
• Don’t wait for the government response or the final instrument before starting this audit. The scope of a restriction is far harder to plan around at the last minute than early.
• If any application looks like it might rely on the proposed aerospace, defence or medical device exemption, flag it now so you can check the exemption’s actual conditions once they’re confirmed, rather than assuming coverage.
• Set a watching brief for the 14 October proposed adoption date and treat it as the point to reassess, not the point to start.

How we can help

We’re already helping defence and aerospace clients map where these five substance groups sit in their supply chains ahead of the draft becoming law. Get in touch if you’d like us to run this audit against your own product range before the autumn deadlines land.

← Back to Regulatory News